Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Weekly News Recap #Phispers
1. 2379336-76-0
2. Rg6006
3. Abx Mcp
4. Ro7223280
5. 4-((11s,14s,17s)-14-(4-aminobutyl)-11-(3-aminopropyl)-17-(1h-indol-3-ylmethyl)-16-methyl-12,15,18-trioxo-2-thia-4,10,13,16,19-pentazatricyclo(19.4.0.03,8)pentacosa-1(25),3(8),4,6,21,23-hexaen-22-yl)benzoic Acid
6. 4-[(11s,14s,17s)-14-(4-aminobutyl)-11-(3-aminopropyl)-17-(1h-indol-3-ylmethyl)-16-methyl-12,15,18-trioxo-2-thia-4,10,13,16,19-pentazatricyclo[19.4.0.03,8]pentacosa-1(25),3(8),4,6,21,23-hexaen-22-yl]benzoic Acid
7. L-tryptophanamide, N2-((2-mercapto-3-pyridinyl)methyl)-l-ornithyl-l-lysyl-n-((4'-carboxy-3-mercapto(1,1'-biphenyl)-2-yl)methyl)-n2-methyl-, Cyclic (1->3)-thioether
8. 5y6w5n1u0s
9. Zosurabalpina
10. Zosurabalpine
11. Zosurabalpin [inn]
12. Zosurabalpin (usan/inn)
13. Zosurabalpin [usan]
14. Unii-5y6w5n1u0s
15. Chembl5314563
16. Ex-a7717b
17. Gtpl12950
18. Bdbm612246
19. At46791
20. Rg-6006
21. Da-59316
22. Hy-147429
23. Us20240050516, Example 1.00
24. Cs-0564229
25. Ro-7223280
26. D12652
27. 4-{(7s,10s,13s)-10-(4-aminobutyl)-7-(3-aminopropyl)-13-[(1h-indol-3-yl)methyl]-12-methyl-8,11,14-trioxo-5,6,7,8,9,10,11,12,13,14,15,16-dodecahydropyrido[2,3-b][1,5,8,11,14]benzothiatetraazacycloheptadecin-17-yl}benzoic Acid
28. L-tryptophanamide, N2-[(2-mercapto-3-pyridinyl)methyl]-l-ornithyl-l-lysyl-n-[(4'-carboxy-3-mercapto[1,1'-biphenyl]-2-yl)methyl]-n2-methyl-, Cyclic (1-->3)-thioether
29. N2.2.2.1,3-anhydro{n2-[(2-{[2-(aminomethyl)-4'-carboxy[1,1'-biphenyl]-3-yl]sulfanyl}pyridin-3-yl)methyl]-l-ornithyl-l-lysyl-n-methyl-l-tryptophan}
| Molecular Weight | 791.0 g/mol |
|---|---|
| Molecular Formula | C43H50N8O5S |
| XLogP3 | 1.4 |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 11 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 234 |
| Heavy Atom Count | 57 |
| Formal Charge | 0 |
| Complexity | 1320 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
STOCK RECAP #PipelineProspector
NEWS #PharmaBuzz
ABOUT THIS PAGE
13
PharmaCompass offers a list of Zosurabalpin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Zosurabalpin manufacturer or Zosurabalpin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Zosurabalpin manufacturer or Zosurabalpin supplier.
PharmaCompass also assists you with knowing the Zosurabalpin API Price utilized in the formulation of products. Zosurabalpin API Price is not always fixed or binding as the Zosurabalpin Price is obtained through a variety of data sources. The Zosurabalpin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Zosurabalpin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zosurabalpin, including repackagers and relabelers. The FDA regulates Zosurabalpin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zosurabalpin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Zosurabalpin supplier is an individual or a company that provides Zosurabalpin active pharmaceutical ingredient (API) or Zosurabalpin finished formulations upon request. The Zosurabalpin suppliers may include Zosurabalpin API manufacturers, exporters, distributors and traders.
Zosurabalpin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Zosurabalpin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zosurabalpin GMP manufacturer or Zosurabalpin GMP API supplier for your needs.
A Zosurabalpin CoA (Certificate of Analysis) is a formal document that attests to Zosurabalpin's compliance with Zosurabalpin specifications and serves as a tool for batch-level quality control.
Zosurabalpin CoA mostly includes findings from lab analyses of a specific batch. For each Zosurabalpin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Zosurabalpin may be tested according to a variety of international standards, such as European Pharmacopoeia (Zosurabalpin EP), Zosurabalpin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zosurabalpin USP).
